| # | Drug | Count |
|---|---|---|
| 0 | LANADELUMAB-FLYO | 3 |
| 1 | C1 ESTERASE INHIBITOR RECOMBINANT | 2 |
| 2 | DIMENHYDRINATE | 2 |
| 3 | ERGOCALCIFEROL | 2 |
| 4 | HUMAN C1-ESTERASE INHIBITOR | 2 |
| 5 | LISINOPRIL | 2 |
| 6 | MORPHINE SULFATE | 2 |
| 7 | PANTOPRAZOLE | 2 |
| 8 | SODIUM CHLORIDE | 2 |
| 9 | SODIUM CHLORIDE TABLET | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GARADACIMAB | 1 | 0.0013 |
| 1 | LANADELUMAB-FLYO | 3 | 0.0009 |
| 2 | C1 ESTERASE INHIBITOR RECOMBINANT | 2 | 0.0003 |
| 3 | NORGESTIMATE AND ETHINYL ESTRADIOL | 1 | 0.0002 |
| 4 | DIMENHYDRINATE | 2 | 0.0002 |
| 5 | HUMAN C1-ESTERASE INHIBITOR | 2 | 0.0001 |
| 6 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 1 | 0.0001 |
| 7 | TEDUGLUTIDE | 1 | 0.0001 |
| 8 | ERGOCALCIFEROL | 2 | 0.0001 |
| 9 | AZELASTINE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Plasma Kallikrein Inhibitor [EPC] | 3 |
| 1 | Integrin Receptor Antagonist [EPC] | 2 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 3 | Osmotic Laxative [EPC] | 2 |
| 4 | Proton Pump Inhibitor [EPC] | 2 |
| 5 | Provitamin D2 Compound [EPC] | 2 |
| 6 | Anti-IgE [EPC] | 1 |
| 7 | Atypical Antipsychotic [EPC] | 1 |
| 8 | Catecholamine [EPC] | 1 |
| 9 | Corticosteroid [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Kallikrein Inhibitor [EPC] | 3 | 0.0013 |
| 1 | Human C1 Esterase Inhibitor [EPC] | 1 | 0.0003 |
| 2 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 3 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 4 | Integrin Receptor Antagonist [EPC] | 2 | 0.0000 |
| 5 | Catecholamine [EPC] | 1 | 0.0000 |
| 6 | Anti-IgE [EPC] | 1 | 0.0000 |
| 7 | Serotonin Reuptake Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Osmotic Laxative [EPC] | 2 | 0.0000 |